No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
564 |
4. Check minimum number of eventsNone |
564 |
5. Include endpointsNone |
564 |
6. Filter based on genotype QC (FinnGen only) |
564 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M71
- Name in latin
- Cystae bursales
Similar endpoints
↥List of similar endpoints to
Other bursal cyst
based on the number of shared cases.
Similar with more cases:
- Other bursopathies
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3159 | 1842 | 1306 |
| Only index persons | 3020 | 1776 | 1244 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.04 |
| Only index persons | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 54.38 | 54.65 | 54.01 |
| Only index persons | 54.03 | 54.25 | 53.71 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 564 | 342 | 222 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.10 |
| Median age at first event (years) | 57.12 | 54.84 | 60.64 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 502
- Matched controls
- 5019
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M71.3
ICD-10 Finland
Other bursal cyst
4503599627370496.0
323.0
480
*
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
11.3
46.7
92
98
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
6.6
37.4
104
191
M75.1
ICD-10 Finland
Rotator cuff syndrome
4.9
35.5
131
336
N03AX16
ATC
pregabalin; oral
3.9
32.6
161
541
M48.0
ICD-10 Finland
Spinal stenosis
5.2
32.2
110
257
M67.4
ICD-10 Finland
Ganglion
11.3
32.2
62
62
M79.6
ICD-10 Finland
Pain in limb
3.2
28.7
190
792
N03AX12
ATC
gabapentin; oral
4.4
27.9
112
306
M54.4
ICD-10 Finland
Lumbago with sciatica
4.1
27.7
123
370
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
25.6
27.4
38
16
N02AX02
ATC
tramadol; systemic, rectal
2.8
26.4
248
1286
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.5
25.9
82
173
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
41.2
25.2
31
8
L03
ICPC
Low back symptom/complaint
3.2
24.7
156
617
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
4.0
24.3
109
328
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
23.3
255
1412
7275X
ICD-9 Finland
Other disorders of synovium, tendon and bursa, Rupture of synovium[CYSTA SYNOVIALIS ALIA LOCO DEFINITO]
+∞
23.1
22
*
NGM20
NOMESCO Finland
Excision of synovial ganglion of knee or lower leg
229.5
21.8
22
*
M25.5
ICD-10 Finland
Pain in joint
2.8
21.2
168
758
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.3
21.1
83
219
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
50.2
20.3
24
5
M01AH05
ATC
etoricoxib; oral
2.4
19.9
317
2079
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
30.3
19.8
26
9
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
11.3
19.7
37
35
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
9.7
19.2
39
43
SPAT1153
SPAT
Removal of sutures
2.5
18.1
189
982
H02AB06
ATC
prednisolone; systemic
2.3
17.2
249
1512
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.3
17.2
66
169
N02BE01
ATC
paracetamol; systemic, rectal
3.0
17.0
444
3609
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
15.4
159
810
M70.6
ICD-10 Finland
Trochanteric bursitis
3.5
15.0
74
236
M54.3
ICD-10 Finland
Sciatica
5.3
15.0
46
93
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
+∞
14.6
14
*
L17
ICPC
Foot/toe symptom/complaint
2.4
14.3
138
673
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
6.7
14.3
36
57
M54.5
ICD-10 Finland
Low back pain
2.3
14.0
169
921
ABC99
NOMESCO Finland
Other decompressive operation on spinal cord or nerve root
54.9
13.9
16
*
ZXC10
NOMESCO Finland
Use of laser
7.4
13.6
32
46
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
13.4
180
1024
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.1
13.4
53
140
J01DB01
ATC
cefalexin; oral
2.3
13.0
415
3372
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.0
12.9
77
282
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
12.8
119
567
M01AC06
ATC
meloxicam; systemic, rectal
2.1
12.7
192
1143
S18
ICPC
Laceration/cut
2.0
12.5
216
1358
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
5.2
12.3
38
78
L86
ICPC
Back syndrome with radiating pain
4.4
12.2
44
107
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
11.9
226
1465
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
4.2
11.7
44
111
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
7.6
11.4
26
36
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
11.4
177
1055
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
11.3
89
385
M03BX02
ATC
tizanidine; oral
1.9
11.3
304
2228
M01AB05
ATC
diclofenac; systemic, rectal
1.9
11.2
329
2483
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
20.6
11.2
16
8
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.3
11.1
41
102
M54.1
ICD-10 Finland
Radiculopathy
5.3
11.0
33
66
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.0
11.0
64
231
M79.0
ICD-10 Finland
Rheumatism, unspecified
18.3
10.8
16
9
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.9
10.7
69
264
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
6.4
10.6
27
44
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.6
10.5
48
144
L12
ICPC
Hand/finger symptom/complaint
2.7
10.5
76
313
R51.80
ICD-10 Finland
Headache
2.7
10.4
74
301
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.9
10.4
42
114
L15
ICPC
Knee symptom/complaint
2.3
10.3
110
556
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
8.2
10.2
22
28
A02BC05
ATC
esomeprazole; systemic
1.9
10.2
204
1328
M43.1
ICD-10 Finland
Spondylolisthesis
5.0
10.1
32
68
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
17.1
9.9
15
9
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
9.7
108
553
J01AA02
ATC
doxycycline; systemic
2.0
9.7
389
3193
L08
ICPC
Shoulder symptom/complaint
2.3
9.6
91
434
9473
FHL
Local soft tissue removal or exploration (eg Bursa)
30.6
9.4
12
*
G44.2
ICD-10 Finland
Tension-type headache
2.6
9.4
69
286
J01FA10
ATC
azithromycin; systemic
1.8
9.4
277
2039
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.2
9.2
103
527
M02AA07
ATC
piroxicam; topical
1.9
9.2
184
1187
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
8.5
9.1
19
23
NBG10
NOMESCO Finland
Acromioplastia
37.4
9.0
11
*
N06AX21
ATC
duloxetine; oral
2.8
8.9
59
229
G04BD12
ATC
mirabegron; oral
2.8
8.9
59
229
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
12.8
8.9
15
12
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.6
8.9
65
267
J01DA01
ATC
[U] cefalexin; systemic
1.8
8.9
308
2365
M01AE02
ATC
naproxen; oral, rectal
1.8
8.9
275
2039
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
4.7
8.8
29
65
N06AX11
ATC
mirtazapine; oral
1.9
8.8
151
919
M03BC01
ATC
orphenadrine (citrate); systemic
2.1
8.8
113
614
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.9
8.7
19
25
N06AA09
ATC
amitriptyline; systemic
2.9
8.6
53
197
J01CA04
ATC
amoxicillin; systemic
1.9
8.6
389
3243
J01FF01
ATC
clindamycin; systemic
2.0
8.5
135
795
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
8.4
60
245
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
8.4
186
1233
N04BC05
ATC
pramipexole; oral
3.1
8.3
44
149
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
7.3
8.3
19
27
ZXA00
NOMESCO Finland
Right side
1.9
8.2
136
814
SPAT1301
SPAT
No procedures
1.9
8.1
155
975
J01MA02
ATC
ciprofloxacin; systemic
1.8
8.1
188
1262
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
17.5
8.1
12
7
M01AX17
ATC
nimesulide; oral
2.0
8.1
117
666
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.6
8.1
61
258
M01AH02
ATC
rofecoxib; oral
2.4
8.0
71
324
M79.7
ICD-10 Finland
Fibromyalgia
7.4
8.0
18
25
M15
ICD-10 Finland
Polyarthrosis
4.0
8.0
31
82
M01AH01
ATC
celecoxib; oral (coxibs)
2.1
7.9
92
477
SPAT1312
SPAT
General health counselling
1.8
7.9
153
967
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
7.8
328
2618
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
4.1
7.8
29
74
M77.1
ICD-10 Finland
Lateral epicondylitis
3.6
7.8
34
100
QCA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of upper limb
45.7
7.7
9
*
M01AX05
ATC
glucosamine; oral
2.0
7.7
104
576
L13
ICPC
Hip symptom/complaint
2.2
7.6
78
383
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.4
7.5
35
108
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
7.5
134
821
L16
ICPC
Ankle symptom/complaint
2.7
7.5
49
191
M20.1
ICD-10 Finland
Hallux valgus (acquired)
2.8
7.4
46
172
A02BC03
ATC
lansoprazole; oral
1.8
7.4
140
876
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
3.3
7.3
36
116
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.9
7.3
129
787
R52.1
ICD-10 Finland
Chronic intractable pain
16.0
7.3
11
7
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.3
7.2
67
315
J01FA06
ATC
roxithromycin; oral
1.7
7.2
197
1377
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.4
7.2
33
101
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
7.1
138
865
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
9.0
7.1
14
16
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
9.0
7.1
14
16
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.6
7.0
23
52
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
7.1
7.0
16
23
L01
ICPC
Neck symptom/complaint
2.3
6.9
64
299
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
14.0
6.9
11
8
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.7
6.9
47
187
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.6
6.8
50
207
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
4.2
6.8
24
59
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
6.8
88
477
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
40.6
6.8
8
*
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
17.0
6.8
10
6
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
6.8
117
707
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
6.7
224
1645
M71.9
ICD-10 Finland
Bursopathy, unspecified
22.9
6.7
9
*
SPAT1263
SPAT
Sampling
1.7
6.7
202
1444
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
6.7
93
520
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
6.6
433
3842
P01BA02
ATC
hydroxychloroquine; oral
2.7
6.6
44
174
AA1AD
NOMESCO Finland
CT of head and brain
1.9
6.6
109
649
J45
ICD-10 Finland
Asthma
2.5
6.5
49
207
X58
ICD-10 Finland
Exposure to other specified factors
2.2
6.5
64
308
G57.6
ICD-10 Finland
Lesion of plantar nerve
5.8
6.5
17
30
ACC51
NOMESCO Finland
Release of median nerve
2.9
6.5
37
132
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
6.5
180
1255
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
14.5
6.4
10
7
A02BC02
ATC
pantoprazole; systemic
1.6
6.4
308
2481
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
6.1
6.3
16
27
J01MA12
ATC
levofloxacin; systemic
1.9
6.3
95
545
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
18.3
6.3
9
5
ZXC50
NOMESCO Finland
Cryotherapy
4.2
6.3
22
54
C08CA05
ATC
nifedipine; systemic
3.0
6.3
34
119
M47.82
ICD-10 Finland
Other spondylosis, cervical region
4.0
6.3
23
59
M47.9
ICD-10 Finland
Spondylosis, unspecified
4.6
6.2
20
45
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
6.2
80
432
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
5.9
6.2
16
28
R06.0
ICD-10 Finland
Dyspnoea
1.8
6.2
109
661
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.4
6.2
50
221
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
6.1
151
1014
M70.2
ICD-10 Finland
Olecranon bursitis
5.3
6.1
17
33
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
6.0
54
250
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
423
3315
2.10
13.07
5.5
3.7
mm/h
10.7
12.5
2.41
407
3022
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
202
1254
1.95
12.23
2.7
2.0
u/l
319.0
282.4
0.08
188
1175
(3035350) Ketones [Presence] in Urine by Test strip
301
2154
1.85
11.54
4.7
3.5
estimate
0.0
0.0
0.00
48
406
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
437
3537
2.05
11.36
8.4
7.6
u/l
69.8
78.9
8.49
416
3318
(3009261) Glucose [Presence] in Urine by Test strip
303
2195
1.82
10.95
4.9
3.4
estimate
0.0
0.0
0.00
52
397
(3021601) Nitrite [Presence] in Urine by Test strip
300
2178
1.81
10.66
6.2
4.7
estimate
0.0
0.0
0.00
53
410
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
287
2061
1.80
10.54
4.3
3.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
241
1654
1.80
10.22
4.0
3.4
ng/l
26.8
36.7
0.94
168
1154
(3019150) Specific gravity of Urine by Refractometry
153
914
1.92
10.08
5.6
3.8
kg/l
1.0
1.0
0.22
28
128
(3031040) Bacteria [#/volume] in Urine by Automated count
372
2909
1.82
10.03
5.5
4.1
e6/l
294.0
3769.4
—
5
54
(42870588) Differential panel, method unspecified - Blood
217
1453
1.80
9.92
6.2
5.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
518
4565
2.65
9.69
17.6
12.9
mg/l
22.0
25.2
1.18
424
3522
(3032080) INR in Blood by Coagulation assay
256
1816
1.75
9.49
7.7
8.9
inr
1.1
1.2
2.60
62
536
(3019198) Lymphocytes [#/volume] in Blood
300
2246
1.72
9.00
7.3
5.6
e9/l
1.8
2.0
1.09
277
1968
(3029937) Albumin [Presence] in Urine by Test strip
176
1135
1.80
8.95
5.2
3.7
estimate
0.0
0.0
0.50
53
395
(3037467) Urinalysis macro (dipstick) panel - Urine
384
3081
1.77
8.95
5.1
4.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
99
529
2.06
8.87
1.3
1.3
titre
613.3
485.2
0.29
18
100
(3006315) Basophils [#/volume] in Blood
295
2204
1.71
8.87
7.3
5.5
e9/l
0.0
0.0
0.58
269
1899
(3013115) Eosinophils [#/volume] in Blood
302
2273
1.71
8.82
7.3
5.8
e9/l
0.2
0.2
2.07
275
1996
(3001604) Monocytes [#/volume] in Blood
294
2199
1.70
8.77
7.2
5.5
e9/l
0.6
0.6
0.21
268
1890
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
113
637
1.97
8.71
1.3
1.2
u/ml
16.8
18.8
0.09
40
244
(3042936) Bacteria identified in Isolate by Culture
106
585
2.00
8.68
2.0
2.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
490
4265
2.13
8.63
5.6
4.5
mu/l
1.9
1.9
0.49
448
3858
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
202
1370
1.74
8.57
2.6
2.3
u/l
57.0
58.9
0.42
188
1262
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
424
3527
1.81
8.46
4.6
3.8
pmol/l
14.8
14.8
0.17
392
3175
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
233
1688
1.65
7.49
5.2
3.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
115
684
1.86
7.47
1.3
1.2
iu/ml
25.9
39.1
1.13
33
224
(3002030) Lymphocytes/100 leukocytes in Blood
279
2122
1.62
7.32
6.9
5.7
%
28.1
28.0
0.04
267
1968
(3018010) Neutrophils/100 leukocytes in Blood
274
2083
1.61
7.15
7.0
5.5
%
56.3
57.0
0.45
262
1947
(40761535) Cells panel - Urine sediment
67
335
2.13
7.11
5.2
3.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
172
1172
1.67
6.91
4.1
3.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
270
2073
1.58
6.58
7.4
5.8
%
9.1
8.8
0.85
259
1935
(40761511) CBC panel - Blood by Automated count
529
4857
2.44
6.41
17.5
12.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
262
2006
1.57
6.41
6.8
5.6
%
0.8
0.7
1.63
252
1864
(3006504) Eosinophils/100 leukocytes in Blood
268
2065
1.57
6.36
7.0
5.6
%
3.1
2.8
1.87
254
1916
(3013826) Glucose [Moles/volume] in Serum or Plasma
324
2607
1.57
6.35
4.8
4.5
mmol/l
6.6
6.7
0.72
310
2439
(3000475) Leukocytes [#/volume] in Synovial fluid
26
87
3.08
6.31
1.3
1.8
e6/l
16354.9
9558.8
0.33
15
68
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
326
2632
1.57
6.25
2.8
2.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
321
2583
1.56
6.24
10.2
9.5
e9/l
3.8
4.0
1.20
292
2267
(3021788) Differential panel - Synovial fluid
21
62
3.48
6.20
1.3
1.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
526
4831
2.32
6.13
19.7
15.1
mmol/l
139.5
139.7
1.07
516
4684
(3026493) Urate [Moles/volume] in Serum or Plasma
159
1093
1.63
6.06
3.0
2.7
umol/l
5194.4
9449.7
0.55
146
942
(40768804) Tissue Pathology biopsy report
239
1811
1.55
6.01
2.4
2.1
—
—
—
0
0
(3013512) EKG study
185
1331
1.58
5.79
4.0
3.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
282
2228
1.53
5.79
7.7
6.6
mmol/l
1.2
1.2
0.05
239
1884
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
294
2344
1.53
5.79
6.0
6.7
umol/l
9.7
11.3
4.52
281
2226
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
133
886
1.66
5.70
1.4
1.7
mg/l
0.9
1.2
1.08
96
694
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
487
4378
1.82
5.69
6.1
5.4
mmol/mol
39.2
39.6
0.57
454
4024
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
507
4619
1.97
5.63
5.2
4.4
mmol/l
5.9
5.9
0.54
465
4180
(3023103) Potassium [Moles/volume] in Serum or Plasma
525
4846
2.21
5.57
20.0
15.3
mmol/l
4.0
4.0
0.04
514
4690
(3012095) Magnesium [Moles/volume] in Serum or Plasma
113
726
1.70
5.54
3.3
3.3
mmol/l
0.8
0.8
0.03
99
687
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
536
4994
2.48
5.48
12.7
10.1
u/l
25.5
25.9
0.28
516
4793
(3045414) Leukocytes [Presence] in Urine
38
168
2.35
5.43
2.3
1.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
258
2022
1.51
5.38
6.6
5.7
mmol/l
1.2
1.2
0.69
228
1832
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
149
1037
1.59
5.31
2.5
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
57
302
1.99
5.20
1.4
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
98
2.73
5.15
1.2
1.4
—
—
—
0
0
(4010399)
60
325
1.95
5.14
1.3
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
15
40
3.83
5.12
1.4
1.5
%
54.9
54.2
—
8
32
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
12
27
4.52
5.06
3.2
2.2
%
17.0
15.4
—
7
12
(3024561) Albumin [Mass/volume] in Serum or Plasma
250
1966
1.49
5.02
4.9
4.7
g/l
35.7
35.5
0.21
232
1841
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
173
1264
1.53
4.93
2.7
3.1
ng/l
1370.3
1329.1
0.04
146
1073
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
91
2.71
4.71
1.4
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
548
5198
2.91
4.66
26.5
19.4
e9/l
249.2
250.5
0.17
541
5052
(3024731) MCV [Entitic volume]
548
5198
2.91
4.66
26.4
19.3
fl
91.9
91.3
2.57
543
5104
(3048689) Calprotectin [Mass/mass] in Stool
79
482
1.74
4.64
2.0
2.4
ug/g
119.9
136.8
0.26
60
382
(3035941) MCH [Entitic mass]
548
5199
2.91
4.64
26.4
19.3
pg
30.6
30.4
2.89
543
5105
(3026361) Erythrocytes [#/volume] in Blood
548
5200
2.90
4.62
26.6
19.4
e12/l
4.4
4.5
2.66
539
5037
(3010813) Leukocytes [#/volume] in Blood
548
5201
2.89
4.60
26.6
19.4
e9/l
6.5
6.6
0.57
540
5039
(3026008) Bacteria identified in Urine by Culture
181
1353
1.50
4.58
3.5
2.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
548
5202
2.88
4.58
26.7
19.4
g/l
134.2
135.2
0.94
543
5106
(3011397) Hemoglobin [Presence] in Urine by Test strip
137
966
1.55
4.54
5.2
3.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
130
916
1.54
4.31
1.3
1.2
u/ml
1.1
2.1
0.73
38
237
(3022217) INR in Platelet poor plasma by Coagulation assay
82
517
1.69
4.28
24.3
22.7
inr
1.1
1.2
—
6
67
(3045424) Erythrocytes [Presence] in Urine
19
67
2.90
4.26
2.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
96
635
1.62
4.16
1.9
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
76
474
1.70
4.13
1.9
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
84
539
1.66
4.10
1.4
1.4
—
—
—
0
0
(4062490)
12
32
3.81
4.10
3.1
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
28
3.99
3.99
3.5
2.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
12
33
3.69
3.94
1.1
1.3
e6/l
28197.6
8431.5
—
7
23
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
24
4.22
3.90
1.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
24
4.22
3.90
1.0
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
182
1399
1.44
3.89
2.7
2.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
13
39
3.39
3.78
3.2
2.2
e9/l
1.3
1.0
—
8
23
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
78
2.62
3.75
1.2
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
90
602
1.59
3.72
1.4
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
126
909
1.50
3.70
2.9
2.4
e6/l
3.4
6.4
2.24
115
804
(3019060) Gas panel - Arterial blood
50
286
1.82
3.66
3.3
4.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
160
1215
1.44
3.61
4.0
3.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
96
657
1.56
3.59
1.6
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
346
3007
1.39
3.51
3.4
3.0
u/l
54.3
51.2
0.12
327
2791
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
82
545
1.59
3.48
7.6
7.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
58
2.81
3.45
1.4
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
95
2.37
3.38
1.2
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
141
1058
1.44
3.37
2.2
2.0
mg/l
2.7
3.1
0.96
116
889
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
198
1579
1.39
3.35
3.5
3.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
49
288
1.77
3.30
3.1
3.0
e9/l
4.0
4.1
0.02
39
224
(3025941) Bacteria identified in Stool by Culture
39
214
1.88
3.27
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
34
178
1.97
3.27
1.7
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
61
385
1.66
3.19
1.7
2.1
nmol/l
348.5
391.4
1.00
56
354
(36304419) Bacteria [Presence] in Urine
152
1171
1.41
3.12
3.0
2.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
52
317
1.71
3.10
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
194
1560
1.37
3.08
3.7
3.5
e6/l
64.9
83.9
0.26
145
1102
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
45
264
1.77
3.06
2.7
3.1
pmol/l
4.3
4.5
1.07
40
234
(3008898) HLA-B27 [Presence]
27
133
2.08
3.06
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
45
2.93
3.04
1.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
45
2.93
3.04
1.1
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
508
4785
1.62
2.99
5.5
4.8
mmol/l
2.7
2.8
0.87
474
4377
(3022948) Iron [Moles/volume] in Serum or Plasma
96
685
1.48
2.96
2.9
2.3
umol/l
14.0
12.9
0.80
85
637
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
46
2.87
2.93
1.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
46
2.87
2.93
1.1
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
21
95
2.26
2.93
1.0
1.3
u/l
16.3
11.3
0.55
15
76
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
497
4662
1.56
2.93
4.9
4.3
mmol/l
1.5
1.5
0.63
466
4266
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
478
4448
1.49
2.92
13.9
12.3
ml/min/173m2
79.2
79.6
0.16
407
3639
(3003458) Phosphate [Moles/volume] in Serum or Plasma
84
585
1.51
2.91
7.7
5.3
mmol/l
1.1
1.0
0.15
78
539
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
499
4687
1.56
2.90
5.1
4.4
mmol/l
4.7
4.7
0.22
470
4318
(3001122) Ferritin [Mass/volume] in Serum or Plasma
228
1895
1.34
2.88
3.1
2.6
ug/l
145.6
138.1
0.22
209
1723
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
47
2.81
2.83
1.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
47
2.81
2.83
1.1
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
40
234
1.76
2.77
1.5
1.3
—
29.4
—
0
16
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
6
8.39
2.75
2.6
2.0
mmol/l
1.2
1.2
—
5
6
(3016502) Oxygen saturation in Arterial blood
67
450
1.55
2.74
4.2
8.2
%
96.1
95.6
0.38
62
434
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
73
500
1.53
2.73
1.6
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
57
369
1.61
2.72
8.4
7.9
mmol/l
9.2
9.9
0.36
52
347
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
93
671
1.46
2.71
2.0
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
37
3.01
2.70
1.0
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
131
1007
1.39
2.69
5.9
4.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
107
794
1.43
2.69
1.7
1.7
nmol/l
1267.0
1231.6
0.14
81
570
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
32
3.16
2.66
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
112
841
1.41
2.63
2.2
1.5
g/l
2.3
2.5
0.31
68
527
(3003396) Base excess in Arterial blood by calculation
74
513
1.51
2.62
4.1
7.6
mmol/l
2.2
1.1
1.58
57
404
(3022145) Colonoscopy Study observation
73
505
1.51
2.61
1.4
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
38
2.93
2.59
2.5
3.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
215
1798
1.32
2.53
2.1
1.9
pmol/l
100.8
94.7
0.93
129
936
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
451
1.52
2.51
1.9
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
45
2.70
2.46
2.3
3.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
187
1540
1.32
2.44
3.0
3.7
mmol/l
2.3
2.4
1.56
166
1357
(3027801) Oxygen [Partial pressure] in Arterial blood
73
513
1.49
2.43
4.2
7.6
kpa
13.2
12.2
0.64
68
491
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
73
513
1.49
2.43
4.2
7.6
kpa
5.0
5.1
0.48
67
489
(3022621) pH of Urine by Test strip
44
275
1.65
2.43
2.8
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
39
236
1.70
2.42
1.8
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
356
1.57
2.41
2.5
2.8
ml/min/173m2
71.3
64.1
0.42
20
147
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
100
748
1.41
2.40
2.4
2.7
e6/l
1.3
1.2
0.09
64
432
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
215
1812
1.30
2.35
2.4
2.2
nmol/l
79.4
77.8
0.38
196
1625
(3018418) pH of Serum or Plasma
165
1343
1.32
2.32
5.2
3.9
ph
7.4
7.4
0.08
24
254
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
68
476
1.49
2.32
1.7
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
77
553
1.45
2.31
1.9
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
44
279
1.63
2.31
1.1
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
24
127
1.93
2.29
1.6
1.7
g/l
0.2
0.2
0.81
24
116
(3019225) pH of Specimen
62
428
1.50
2.26
5.1
4.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
32
187
1.75
2.26
4.4
3.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
175
1442
1.31
2.25
3.6
3.3
u/l
36.3
31.8
0.24
168
1382
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
582
1.44
2.24
4.9
4.4
%
33.7
31.9
0.87
61
372
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
67
471
1.48
2.24
3.4
3.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
479
4512
1.41
2.24
4.4
3.9
mmol/l
1.3
1.3
0.10
445
4113
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
22
114
1.97
2.23
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
129
1.90
2.20
1.3
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
144
1.84
2.18
3.8
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
67
475
1.47
2.15
1.6
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
156
1272
1.31
2.15
1.7
1.6
mmol/l
1.4
1.4
0.39
133
1053
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
81
2.13
2.14
1.2
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
116
1.93
2.13
1.4
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
367
3337
1.29
2.13
4.3
3.6
—
—
—
0
0
(3000492) Spirometry study
60
417
1.49
2.13
1.8
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
124
982
1.34
2.09
1.6
1.7
pmol/l
417.1
13882493.1
0.76
106
814
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
15
4.03
2.04
1.2
1.1
iu/ml
82.2
226.2
—
6
15
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
15
4.03
2.04
1.0
1.2
—
1.1
—
0
5
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
11
44
2.53
2.02
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
44
291
1.56
1.97
1.5
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
149
1223
1.30
1.94
3.2
2.9
e6/l
0.3
0.6
1.09
120
923
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
26
150
1.77
1.94
4.7
4.3
mmol/l
25.9
25.4
0.51
26
145
(3020891) Body temperature
27
158
1.74
1.92
4.6
4.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
45
301
1.54
1.92
2.7
2.0
nmol/l
10.1
13.3
1.65
38
266
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
246
1.58
1.87
4.8
3.8
mmol/l
2.1
2.1
0.01
32
198
(3002582) Erythrocytes [#/volume] in Urine
160
1335
1.28
1.83
3.2
3.0
e6/l
43.8
134.1
0.94
124
1031
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
53
2.29
1.82
1.3
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
23
3.07
1.80
1.9
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
23
131
1.79
1.80
1.6
1.6
g/l
1.1
1.2
1.02
23
121
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
13
60
2.19
1.79
1.1
1.3
pmol/l
381.5
271.5
—
8
47
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
78
591
1.37
1.76
3.1
2.4
%
26.2
22.4
1.26
63
507
(3006653) Thiamine [Moles/volume] in Blood
7
24
2.94
1.72
1.3
1.4
nmol/l
149.9
166.2
—
7
24
(4015189)
5
13
3.87
1.72
1.2
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
13
3.87
1.72
1.6
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
19
3.18
1.66
1.3
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
76
2.00
1.65
3.5
2.9
e9/l
3.6
4.1
0.39
15
76
(3035933) Granulocytes/100 leukocytes in Blood
5
14
3.59
1.62
1.0
1.3
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
14
3.59
1.62
1.0
2.0
%
146.0
120.9
—
5
14
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
43
2.35
1.61
1.4
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
166
1412
1.25
1.60
2.8
3.0
mmol/l
7.3
7.6
0.37
142
1192
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
20
3.02
1.58
1.2
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
43
299
1.47
1.56
5.0
2.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
12
57
2.13
1.56
1.8
1.7
mmol/l
1.4
1.6
0.29
12
57
(3003327) Ova and parasites identified in Stool by Light microscopy
22
130
1.72
1.55
2.0
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
115
1.77
1.54
1.5
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
49
351
1.43
1.54
4.7
3.7
ng/l
90.4
84.5
0.21
43
318
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
13
65
2.02
1.49
2.2
1.5
u/ml
121.6
113.4
—
5
9
(3036489) Thrombin time
25
155
1.64
1.49
1.2
1.7
s
20.4
21.2
0.44
20
140
(21494755) Public health laboratory ask at order entry panel
28
424
0.64
1.49
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
102
825
1.29
1.48
3.7
3.6
ng/l
240.5
493.4
0.63
75
648
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
80
1.90
1.46
3.7
3.2
%
54.5
56.6
0.20
15
80
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
296
1.45
1.44
1.2
1.2
iu/ml
110.8
142.4
0.14
13
116
(3010421) pH of Blood
19
110
1.75
1.44
5.8
3.0
ph
7.4
7.4
0.17
12
80
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
59
2.06
1.44
1.2
1.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
22
2.75
1.44
1.2
2.4
u/l
220.7
207.4
—
6
22
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
39
2.33
1.43
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
159
1362
1.23
1.42
2.9
3.1
mg/l
33.8
283.4
1.74
94
853
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
93
748
1.29
1.42
1.5
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
82
1.85
1.37
1.2
1.3
—
2.9
—
0
6
(3028026) IgM [Mass/volume] in Serum or Plasma
40
283
1.44
1.36
3.6
1.7
g/l
0.8
1.6
3.64
35
256
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
136
1.64
1.34
2.1
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
24
2.52
1.30
1.5
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
18
2.79
1.28
1.0
2.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
18
2.79
1.28
1.0
1.1
miu/ml
750.6
1869.3
—
5
18
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
62
1.96
1.28
1.1
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
84
1.81
1.28
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
77
1.84
1.26
2.1
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
162
1407
1.21
1.26
6.4
4.8
ug/l
2.0
3.2
1.01
153
1239
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
25
2.41
1.24
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
78
1.82
1.22
1.4
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
78
1.82
1.22
1.4
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
228
2050
1.19
1.21
10.8
9.0
e9/l
0.0
0.0
0.74
197
1686
(3002032) Base excess in Venous blood by calculation
54
415
1.33
1.16
4.2
3.5
mmol/l
2.1
2.0
0.08
43
328
(3004789) Transferrin [Mass/volume] in Serum or Plasma
78
631
1.27
1.15
3.1
2.3
g/l
2.3
2.3
0.35
69
587
(3051593) INR in Capillary blood by Coagulation assay
5
20
2.51
1.15
14.4
6.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
20
2.51
1.15
1.0
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
20
2.51
1.15
3.2
3.9
u/ml
401.4
1070.6
—
5
20
(3009542) Hematocrit [Volume Fraction] of Blood
443
4234
1.22
1.12
16.6
14.4
%
38.2
39.7
1.60
280
2984
(40761536) Microorganisms panel - Urine sediment
50
382
1.34
1.12
4.5
3.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
51
1.98
1.12
1.6
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
29
202
1.46
1.10
1.1
1.1
—
104.2
—
0
5
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
14
81
1.75
1.10
1.4
1.1
u/ml
258.6
280.2
—
9
44
(3035637) Corticotropin [Mass/volume] in Plasma
8
41
1.96
1.09
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
124
1066
1.21
1.07
1.5
1.5
nmol/l
23.3
20.6
0.30
112
886
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
10
52
1.94
1.06
1.0
1.1
u/ml
4.8
1.8
—
5
15
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
34
246
1.41
1.06
5.9
10.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
20
130
1.56
1.04
2.5
3.2
mmol/l
3.8
3.9
0.91
20
118
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
19
122
1.58
1.04
1.1
1.8
%
92.5
92.2
0.02
19
114
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
22
2.28
1.03
4.2
2.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
13
75
1.75
1.03
1.7
1.3
mmol/l
96.5
61.8
0.96
13
61
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
131
1136
1.20
1.03
6.7
4.3
%
23.4
21.3
0.46
76
548
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
222
1.42
1.03
2.5
2.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
83
1.70
1.02
1.4
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
48
1.89
1.01
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
163
1445
1.18
1.00
3.6
3.8
mg/mmol
6.9
7.6
0.10
97
907
(3027945) Reticulocytes/100 erythrocytes in Blood
59
471
1.28
0.99
2.3
2.7
%
1.7
1.8
0.23
51
421
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
23
2.18
0.98
1.6
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
38
285
1.36
0.98
2.3
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
100
1.62
0.97
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
77
1.70
0.96
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
51
1.78
0.95
1.6
1.2
—
—
—
0
0
(1002224) Polysomnography panel
26
184
1.43
0.93
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
9
52
1.74
0.92
1.8
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
46
359
1.31
0.92
2.9
3.0
e9/l
66.2
69.8
0.44
36
271
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
30
404
0.73
0.92
1.8
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
71
1.71
0.89
2.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
71
1.71
0.89
1.4
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
14
87
1.62
0.88
1.3
1.2
—
24.4
—
0
11
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
87
1.62
0.88
1.5
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
6
30
2.01
0.87
1.3
2.0
—
35.6
—
0
5
(40758558) Short blood count panel - Blood
127
1116
1.18
0.87
6.3
7.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
44
1.83
0.86
6.4
2.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
129
1.49
0.84
1.5
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
8
46
1.75
0.83
1.4
2.0
%
88.4
89.6
—
8
46
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
321
1.30
0.82
2.2
1.9
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
8
47
1.71
0.81
1.3
1.3
mosm/kgh2o
278.9
278.2
—
8
30
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.1
—
31.7
—
0
18
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
25
0.00
0.79
0.0
1.1
—
83.8
—
0
18
(40767503) Oxygen content in Capillary blood by calculation
13
82
1.60
0.78
3.1
2.5
%
16.0
16.7
—
5
47
(3045716) Anion gap in Serum or Plasma
0
27
0.00
0.77
0.0
2.7
—
9.5
—
0
20
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
27
201
1.36
0.76
4.0
3.7
mmol/l
24.8
24.1
0.74
22
186
(40768795) Lymph node Pathology biopsy report
9
53
1.71
0.75
1.2
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
75
1.61
0.75
4.5
2.7
—
540.4
—
0
8
(3047189) Immunofixation for 24 hour Urine
5
24
2.09
0.74
1.8
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
25
2.01
0.73
1.2
1.2
mg/l
31.0
40.2
—
5
20
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
25
2.01
0.73
1.0
1.1
mg/l
226.6
276.9
—
5
20
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
117
1.47
0.72
1.1
1.2
—
—
—
0
0
(4306422)
9
57
1.59
0.71
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
169
1.38
0.70
1.3
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
42
1.67
0.68
1.1
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
42
1.67
0.68
4.7
3.7
u/ml
39.9
46.3
—
7
42
(3004616) Nuclear Ab [Presence] in Serum
7
42
1.67
0.68
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
119
1.44
0.67
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
162
1.37
0.67
2.5
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
198
1.33
0.65
1.0
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
20
146
1.38
0.64
2.6
3.7
mmol/l
1.5
1.3
0.57
20
141
(40768800) Prostate Pathology biopsy report
6
101
0.59
0.62
1.3
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
45
371
1.23
0.62
5.6
4.3
%
0.3
0.1
0.62
12
103
(3019897) Erythrocyte distribution width [Ratio] by Automated count
8
49
1.64
0.62
8.3
2.0
%
13.2
13.1
—
8
49
(3005570) Glucose [Moles/volume] in Urine
8
49
1.64
0.62
2.3
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
58
492
1.20
0.61
1.3
1.7
%
1.5
1.5
0.11
50
421
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
21
0.00
0.60
0.0
5.7
—
—
—
0
0
(4034850)
19
140
1.37
0.59
12.3
7.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
54
1.49
0.57
1.5
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
150
1.35
0.56
2.4
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
37
1.63
0.55
1.5
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
117
1.38
0.52
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
63
1.44
0.52
2.4
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
34
279
1.23
0.51
1.8
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.50
1.6
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
84
1.44
0.49
2.3
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
40
336
1.21
0.49
1.3
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
45
1.56
0.49
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
111
0.63
0.48
1.9
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
47
1.50
0.47
1.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
68
1.48
0.47
2.1
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
48
1.46
0.47
2.0
2.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
119
0.67
0.46
1.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
120
0.66
0.46
4.8
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
112
1.35
0.45
9.1
3.9
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
18
139
1.30
0.44
2.6
1.6
—
200.0
—
0
5
(3017181) Myelocytes/100 leukocytes in Blood
46
397
1.17
0.43
5.9
4.2
%
0.9
0.9
0.01
12
116
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
104
1.35
0.43
1.1
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
43
370
1.18
0.42
6.5
8.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
22
271
0.80
0.41
1.5
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
(4024509)
5
34
1.47
0.40
2.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
60
1.34
0.40
1.0
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.3
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
61
1.32
0.39
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
167
1771
0.92
0.39
2.9
2.9
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
19
0.00
0.39
0.0
4.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
19
0.00
0.39
0.0
6.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
61
544
1.14
0.38
5.2
6.8
mmol/l
104.1
104.3
0.14
61
526
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
1.4
1.5
g/l
0.9
1.1
—
5
36
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
67
1.35
0.38
2.1
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
42
365
1.16
0.37
5.5
4.0
%
0.6
0.7
—
9
87
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
114
0.70
0.37
1.8
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
116
1.30
0.37
1.5
1.3
miu/ml
206.2
232.9
—
7
51
(3025159) Blasts/100 leukocytes in Blood
41
357
1.16
0.36
6.0
4.3
%
0.0
0.1
—
9
92
(3050129) First trimester maternal screen panel - Serum or Plasma
5
76
0.65
0.36
1.4
1.5
—
—
—
0
0
(4146454)
6
42
1.43
0.35
2.7
2.5
—
—
—
0
0
(4094501)
16
126
1.28
0.35
1.1
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
27
227
1.20
0.35
2.0
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
134
1263
1.08
0.31
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
54
1.30
0.30
1.1
1.3
nmol/l
—
—
—
0
0
(3026782) Osmolality of Urine
92
856
1.09
0.29
3.4
2.7
mosm/kgh2o
521.0
557.5
1.03
84
734
(1616796) Gas panel - Central venous blood
11
85
1.30
0.28
4.0
3.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
149
1.21
0.28
1.3
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
64
1.25
0.27
2.0
2.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
15
122
1.24
0.27
1.4
1.4
ug/g
264.0
315.6
—
7
69
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
72
1.25
0.25
1.1
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
76
1.19
0.24
6.0
2.9
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
31
274
1.14
0.24
4.7
9.0
%
1.5
1.3
0.62
31
269
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
106
1.23
0.23
1.2
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
88
1.25
0.22
2.0
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
31
276
1.13
0.22
4.7
9.0
%
0.6
0.7
1.72
31
271
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.6
—
38.2
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
18.3
—
0
10
(3013293) Extractable nuclear Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
14.0
—
0
12
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
25
221
1.14
0.20
3.4
3.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
99
1.22
0.19
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
99
1.22
0.19
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
99
1.22
0.19
1.1
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
60
1.17
0.18
3.6
2.5
pg
34.7
33.3
—
7
60
(3016879) Cocaine [Presence] in Urine
11
91
1.21
0.17
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
86
818
1.06
0.17
3.8
3.0
ug/l
0.7
0.8
0.55
66
555
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
66
0.76
0.17
1.0
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
19
215
0.88
0.17
2.2
3.6
u/ml
7.4
1195.6
1.02
11
190
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
89
848
1.06
0.17
3.3
3.1
mmol/l
2.5
2.5
0.05
78
761
(3044290) Cell count panel - Cerebral spinal fluid
8
68
1.18
0.16
1.1
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
71
1.13
0.16
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
78
0.77
0.15
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
197
1.12
0.15
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
64
606
1.06
0.15
1.2
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
12
104
1.16
0.12
3.0
1.9
g/l
0.0
0.0
0.00
12
94
(3001019) Free T4 and TSH panel - Serum or Plasma
22
240
0.91
0.11
1.9
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
157
0.89
0.11
2.7
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
134
1.12
0.11
2.0
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
36
382
0.94
0.10
7.6
3.3
mmol/l
1.2
1.2
0.18
29
329
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
12
106
1.13
0.10
3.0
1.9
g/l
0.0
0.0
0.00
12
95
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.2
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
47
1.06
0.09
2.4
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
57
1.05
0.08
4.7
2.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
61
0.82
0.08
2.2
1.4
—
—
—
0
0
(44806118)
5
62
0.80
0.08
1.6
1.6
—
—
—
0
0
(44790047)
5
62
0.80
0.08
1.6
1.6
—
—
—
0
0
(44790049)
5
62
0.80
0.08
1.6
1.6
—
—
—
0
0
(44790048)
5
62
0.80
0.08
1.6
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
63
0.79
0.08
1.8
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
123
0.89
0.08
1.1
1.3
—
—
—
0
0
(4035726)
44
459
0.96
0.07
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
70
0.86
0.07
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
1.6
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
143
0.91
0.07
2.9
1.9
g/l
9.2
10.8
1.60
13
117
(3019230) Fractional oxyhemoglobin in Venous blood
8
77
1.04
0.07
1.7
2.2
%
57.9
64.1
—
8
77
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
51
529
0.96
0.07
2.7
4.7
ug/l
59.6
34.7
0.18
45
432
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
13
118
1.10
0.07
2.8
2.0
g/l
0.0
0.0
0.00
13
106
(3027944) Amphetamines [Presence] in Urine
11
99
1.11
0.06
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
699
0.97
0.06
2.6
2.9
e6/l
3.0
2.5
0.12
34
385
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
110
0.91
0.05
1.8
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
130
1.08
0.04
3.4
4.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
91
1.10
0.04
3.3
2.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
11
118
0.93
0.03
1.1
1.2
—
110.0
—
0
8
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
107
1.03
0.00
1.7
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
113
0.97
0.00
2.5
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
12
123
0.98
0.00
3.0
1.8
g/l
41.1
37.6
1.36
12
100
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
173
0.98
0.00
2.3
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
183
0.98
0.00
2.0
2.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
25
249
1.00
0.00
4.3
3.4
u/ml
52.1
45.6
0.06
25
240
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
76
0.92
0.00
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
2.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
49
1.02
0.00
1.2
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
7.7
—
0
7
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
37.3
—
0
6
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
1.3
—
0.7
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
85
0.94
0.00
5.0
2.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
58
0.86
0.00
1.4
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
64
0.94
0.00
1.2
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4281824)
6
66
0.91
0.00
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
71
0.99
0.00
1.7
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
66
0.91
0.00
2.8
2.3
u/ml
4.8
5.5
—
6
61
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.2
2.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
54
0.93
0.00
1.6
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
14.2
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
88
0.91
0.00
1.3
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_BURSCYSTOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_BURSCYSTOTH | 1.008 [0.85, 1.2] | 0.927 |
| Birth year | 0.991 [0.98, 1.0] | 0.037 |
During the follow-up period (1.1.1998 — 31.12.2019), 165 out of 1495 females with M13_BURSCYSTOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_BURSCYSTOTH | 0.84 [0.69, 1.02] | 0.081 |
| Birth year | 0.988 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 131 out of 979 males with M13_BURSCYSTOTH died.
Mortality risk
Mortality risk for people of age
years, who have M13_BURSCYSTOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.077% | 0.169% |
| 5 | 0.515% | 1.033% |
| 10 | 1.341% | 2.501% |
| 15 | 2.446% | 4.822% |
| 20 | 4.036% | 8.41% |
Relationships between endpoints
↥Index endpoint: M13_BURSCYSTOTH – Other bursal cyst
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data